Archive for October, 2015
We’re lucky enough to collaborate with amazing clients that inspire great work. Museum of Science, Blue Cross Blue Shield of Massachusetts and the Celtics are three of those clients.
That’s why we’re excited to announce that Allen & Gerritsen brought home 10 awards last night from the Ad Club of Boston’s 55th annual Hatch Awards for our work with these organizations.
From Pixar to Boston Pride to Green Runs Deep, we’re honored to partner with these companies each day, and proud of our team for continuing to be a little badass…and a lot creative.
Museum of Science, Blue Cross Blue Shield and Celtics Win Big at Hatch Awards
We’re lucky enough to collaborate with amazing clients that inspire great work. Museum of Science, Blue Cross Blue Shield of Massachusetts and the Celtics are three of those clients. That’s why we’re excited to announce that Allen & Gerritsen brought home 10 awards last night from the Ad Club of Boston’s 55th annual Hatch Awards […] »
Company features water tight cable assemblies to IP 67 and 69 Approvals
Lowell, Massachusetts, – Segue Manufacturing Services, a leading vertically integrated manufacturing solutions company, recently has expanded their medical cable assembly
over molding capability with advanced solutions solving water tight applications requiring IP 67 and IP 68 specifications.
The Ingress Protection Rating System (IP) is a classification system showing the degrees of protection from solid objects and liquids. Waterproof Interconnects can be classified into different grades including IP67 and IP68 for waterproof connectors. IP 67 rating means the interconnect is capable of withstanding water immersion between 15 cm and 1 meter for 30 minutes. IP68 waterproof interconnects are designed for demanding environment and continuous water immersion.
“Segue specializes in medical cable assemblies and we see this as a growing segment of our business. We expect the medical cable assembly market to grow from 36 percent of our business to 50 percent. The medical cable assembly market is a very competitive area and time to market and a successful product launch is critical”, said Mark Griffith, Segue’s Vice President of Global Sales & Marketing. “Segue’s agility and flexibility allows us to outperform the competition and gain the trust and
credibility of our customers, Griffith also stated.
“We also see medical cable assemblies as a growth area since we are vertically integrated. We can build smart cables, for example, requiring an over molded PCBA that we can manufacture in house and offer in house over-molding or injection molded plastic housings that get ultrasonically welded. We just added additional capacity by investing in more ultrasonic welding machines to insure that we stay positioned in this area and can continue to offer quick delivery and capacity to our customers,”
Segue also offers clean room manufacturing environment to support their medical customers in their Lowell, MA headquarters and in their Xiamen manufacturing facility that features 100,000 sq. ft of manufacturing space employing over 450 people.
Griffith also stated, that Segue attracts medical customers based on extensive capabilities including engineering services and a strong quality management system including medical ISO 13485, ISO 9001, UL / CSA certifications and our IPC certified operators.
About Segue Manufacturing Services
Segue Manufacturing Services is a U.S. owned and operated, global contract manufacturer providing a portfolio of engineering services and manufacturing capabilities from sub-assembly level to complete end-to-end manufacturing in a lean manufacturing environment. We provide our customers a competitive edge through a comprehensive suite of cost-effective manufacturing services that is unavailable from most regional contract manufacturers. From low-to-moderate volumes, high-mix production and new product introduction in the United States, we transition to high-volume, complex assemblies at our facility in Xiamen, China. For more information about Segue Manufacturing Services, please visit us at http://www.segue-mfg.com/medical-cable-assemblies/
For Additional Information Contact: email@example.com
Segue Manufacturing Services Expands Medical Cable Assembly Capabilities
Company features water tight cable assemblies to IP 67 and 69 Approvals Lowell, Massachusetts, – Segue Manufacturing Services, a leading vertically integrated manufacturing solutions company, recently has expanded their medical cable assembly over molding capability with advanced solutions solving water tight applications requiring IP 67 and IP 68 specifications. The Ingress Protection Rating System (IP) is a […] »
Canton, Mass – Three new real-world, comparative effectiveness analyses reporting the clinical outcomes of Apligraf® for the treatment of hard-to-heal venous leg ulcers (VLUs), and Dermagraft® for the treatment of chronic diabetic foot ulcers (DFUs), were recently presented at the Fall Symposium for Advanced Wound Care (SAWC) annual medical meeting in Las Vegas, Nev. Apligraf® and Dermagraft® are the only living cell-based products in the “skin substitute” category to have received FDA approval for chronic wound healing. They are both manufactured by Organogenesis Inc., a global leader in regenerative medicine for wound healing.
The findings of these studies report the effectiveness of Apligraf and Dermagraft living cell-based therapies, compared to Epifix, Primatrix and Theraskin, including a reduction in healing times for chronic wounds when advanced, FDA-approved Apligraf and Dermagraft products were utilized.
“The results of these comparative effectiveness studies provide further evidence of the real world effectiveness of our FDA-approved biotherapeutics for chronic and sometimes life-threatening wounds like DFUs and VLUs, showing how they work in the hands of hundreds of clinicians in routine clinical settings across the United States,” said Gary S. Gillheeney, Sr., president and CEO of Organogenesis Inc. “As the number of people living with diabetes continues to grow, along with the increased prevalence of patients suffering from chronic wounds, it’s critical we continue researching and promoting effective advanced wound care treatments.”
Highlights from the analyses in diabetic foot ulcers (DFUs):
“Comparative Effectiveness of a Human Fibroblast Dermal Substitute vs. a Dehydrated Human Amniotic Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real World Setting” evaluated the real-world comparative effectiveness of Dermagraft versus Epifix for the treatment of DFUs. The analysis assessed real-world outcomes in 122 DFU patients receiving treatment at 72 wound care centers in 2014. Major findings:
- Use of Dermagraft had improved outcomes compared to Epifix for the treatment of DFUs in real?world settings, as Dermagraft-treated wounds were found to have a significantly higher incidence of wound closure compared with Epifix-treated wounds.
- The median time to closure for patients treated with Dermagraft was 12 weeks compared to 19.4 weeks for patients treated with Epifix, or 38% sooner.
- The probability of healing with Dermagraft was twice as high as the probability of healing with Epifix.
“Comparative Effectiveness of a Human Fibroblast?derived Dermal Substitute vs. a Fetal Bovine Collagen Dressing for the Treatment of Diabetic Foot Ulcers in a Real World Setting” assessed real-world outcomes in 206 patients with 208 DFUs receiving treatment in 2014 at 93 wound care centers with either Dermagraft or Primatrix. Major findings:
- Use of Dermagraft was significantly more effective than Primatrix for the treatment of DFUs in real-world settings, and patients treated with Dermagraft healed on average 42% faster than patients treated with Primatrix (14.6 weeks versus 25 weeks, respectively).
- Treatment with Dermagraft increased the probability of healing by 77% compared to Primatrix collagen dressing.
“A Comparative Effectiveness Analysis of a Bioengineered Living Cellular Construct and Cryopreserved Cadaveric Skin Allograft for the Treatment of Venous Leg Ulcers in a Real World Setting” looked at healing times for patients using Apligraf versus Theraskin to treat venous leg ulcers (VLUs). Major findings:
- Data for 717 patients with 799 VLUs receiving treatment at 177 wound care centers found the median time to closure with the use of Apligraf was 52% faster than for Theraskin (15 weeks versus 31 weeks, respectively).
- The probability of healing increased by 97% with the use of Apligraf, when compared to treatment with Theraskin.
The three studies presented at SAWC are the latest in a series from Organogenesis’ major ongoing program to analyze the Net Health WoundExpert database , the largest electronic medical record (EMR) system in the wound care field, in order to evaluate the clinical performance and comparative effectiveness of Organogenesis’ products in a real-world setting. The efficacy of Organogenesis products has been established through rigorous premarket approval studies required for FDA approval.
These analyses follow a June 2015 study, utilizing the same WoundExpert national EMR system and published in the peer-reviewed Wound Repair & Regeneration, which found that the probability of healing diabetic foot ulcers (DFUs) increases by 97% when treated with Apligraf when compared with Epifix. DFUs treated with Apligraf closed twice as fast as those treated with Epifix, according to the comparative effectiveness study.1
Additionally, a March 2015 study, published in the peer-reviewed Journal of Medical Economics, assessed the real-world medical resource utilization and Medicare costs associated with the use of Apligraf and Dermagraft relative to conventional wound care in DFU patients. The data showed significantly improved outcomes and economic benefits of both Apligraf and Dermagraft in the treatment of DFUs, utilizing de-identified patient records from the Medicare database.2
Having pioneered the field, Massachusetts-based Organogenesis Inc. is a world leading regenerative medicine company focused in the areas of bio-active wound healing and soft tissue regeneration. The company’s mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. For more information, visit www.organogenesis.com.
Comparative Effectiveness Analyses Report Faster Healing Times, Improved Probability of Chronic Wound Closure with Apligraf® and Dermagraft®
Canton, Mass – Three new real-world, comparative effectiveness analyses reporting the clinical outcomes of Apligraf® for the treatment of hard-to-heal venous leg ulcers (VLUs), and Dermagraft® for the treatment of chronic diabetic foot ulcers (DFUs), were recently presented at the Fall Symposium for Advanced Wound Care (SAWC) annual medical meeting in Las Vegas, Nev. Apligraf® and Dermagraft® are the […] »
Horizons for Homeless Children has a mission to improve the lives of young homeless children in Massachusetts and help their families succeed. A noble and important mission and one that Allen & Gerritsen is honored to be associated with. A&G has been selected by the local nonprofit to fully redesign its digital platform. A&G, with offices in Boston and Philadelphia, is tasked with creating a user experience that clearly communicates this mission while supporting development, volunteer and advocacy initiatives. “At A&G we strive to create awe inspiring work,” said Andrew Graff, CEO of Allen & Gerritsen. “We are humbled to be able to create this work for an organization that is providing support to 2,000 homeless children every week.”
Allen & Gerritsen to Redesign Digital Platform for Horizons for Homeless Children
Horizons for Homeless Children has a mission to improve the lives of young homeless children in Massachusetts and help their families succeed. A noble and important mission and one that Allen & Gerritsen is honored to be associated with. A&G has been selected by the local nonprofit to fully redesign its digital platform. A&G, with […] »
New Platform as a Service model allows customers to quickly realize the financial and operational benefits of Bigbelly’s innovative approach to waste management
NEEDHAM, Mass. – Bigbelly, Inc., the leader in smart waste and recycling systems, today announced Connect™, a turnkey smart waste and recycling system that ensures customer engagement, satisfaction, and success. This Platform as a Service (PaaS) encompasses hardware, software, services, installation, cleaning, inspection, and warranty, all for a low monthly fee. Customers can embrace full scale system deployments and immediately realize the benefits of increased operational efficiency and cleaner communities, streets, parks, and campuses.
“Working with our most successful customers, we realized the greatest satisfaction came when customers were fully engaged with our system,” said Jack Kutner, Bigbelly’s CEO. “Those who got to full scale immediately and optimized their system deployment gained the most efficiencies, economies of scale, and the quality of life benefits our system provides.”
Connect offers a number of benefits including a customized fleet of Bigbelly & Smartbelly stationsand associated options and accessories, unlimited mobile and desktop software licenses, and ongoing customer service and support. Leveraging Connect’s software and cloud connectivity, customers – municipalities, colleges & universities, healthcare facilities, and corporations – can make data-backed operational decisions based on real-time system information, historical analysis, and reporting.
Connect is designed for customers to easily engage and leverage ongoing Bigbelly services, including automated system monitoring for optimal performance and operational efficiency. After initial site mapping and station configuration consulting, hardware installation, and onboarding, customers receive ongoing service and support, best practices, cleaning service, and annual inspections as part of a standard 60-month service agreement.
Kutner continued, “Adding a complete turnkey service package enables customers to focus on their waste efforts. When we combine our extensive consulting and support with our proven hardware and software in one complete package offered for a low monthly fee, we can enable even more customers worldwide to benefit from a full scale deployment right out of the gate, and dramatically improve their public space waste and recycling efforts.”
Pricing and Availability
Connect is available directly from Bigbelly, and a network of distributors and service providers worldwide. Deployed as a PaaS installation model, customers can take advantage of a pricing model that scales to meet their unique waste and recycling needs. Additional information on Connect is available at Bigbelly.com.
Bigbelly, Inc. is the world-leading provider of smart waste & recycling management solutions with more than 1,500 customers in 47 countries. Solar powered, Bigbelly’s Connect combines cloud computing with smart compacting waste and recycling stations and comprehensive services. The system helps customer beautify their public space and reduce operational costs by 70-80 percent.
Bigbelly Launches Connect™ – a Turnkey Enterprise Wide System for Smart Waste and Recycling
New Platform as a Service model allows customers to quickly realize the financial and operational benefits of Bigbelly’s innovative approach to waste management NEEDHAM, Mass. – Bigbelly, Inc., the leader in smart waste and recycling systems, today announced Connect™, a turnkey smart waste and recycling system that ensures customer engagement, satisfaction, and success. This Platform as a […] »